Well done to all six teams from Domainex who took on the 3 Peaks challenge to raise money for Tŷ Hafan! This amazing charity helps life-limited children in Wales to make the most of the time they have left together with their families.
There is still time to donate: https://www.justgiving.com/team/Domainex3peaks?invite=true
Bicycle Therapetuics and MRC Laboratory of Molecular Biology have shared a recent publication in Nature Communications describing the effectiveness of Bicycles as antivirals against SARS-CoV-2.
Read the full publication here: https://www.nature.com/articles/s41467-023-39158-1.epdf?sharing_token=MB...
Discover state-of-the-art Category II wet lab space, co-loacted with world experts in vaccines and stemcells at the Royal Veterinary College's (RVC) Centre for Vaccinology and Regenerative Medicine (CVRM) in the beautiful Hertfordshire countryside.
Read more: https://www.lbic.com/lbic-cvrm
17 June 2023
ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women’s health, has announced the acquisition of the scientific assets of Imagen Therapeutics Limited from its appointed liquidators for £170,000.
UK pharmaceutical services company Imagen offered personalised cancer treatment through the collection and use of well-characterised, patient-derived cells.
• Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio.
• Agreement to utilize PrecisionLife’s combinatorial analytics platform to identify genetic biomarkers that will optimize patient selection across multiple CNS clinical trials.
AMSBIO is a leading provider of ready-to-use Adeno-Associated Virus (AAV) that can be engineered to efficiently deliver specific DNA sequences into target cells with a low immunogenicity.
Aptamer Group CTO, Dr David Bunka, will present at Neuro-Bio’s Science Day on Optimer technology and the development of binders to support the diagnostic